Literature DB >> 10922305

Diabetes, hemoglobin A(1c), cholesterol, and the risk of moderate chronic renal insufficiency in an ambulatory population.

C Y Hsu1, D W Bates, G J Kuperman, G C Curhan.   

Abstract

Moderate chronic renal insufficiency is common, with 12.5 million individuals in the United States estimated to have a creatinine clearance less than 50 mL/min/1.73 m(2). Little is known about the risk factors for moderate chronic renal insufficiency. We studied 1, 428 subjects with Cockcroft-Gault-estimated creatinine clearances greater than 70 mL/min in a hospital-based ambulatory population. Over a mean of 5.7 +/- 1.3 years, 86 subjects developed moderate chronic renal insufficiency, defined as a decrease in creatinine clearance to less than 60 mL/min (1.1 case/100 person-years). Risk factors for moderate chronic renal insufficiency were identified using a proportional hazards model controlling for age, sex, race, systolic blood pressure, and angiotensin-converting enzyme (ACE) inhibitor use. The risk for developing moderate chronic renal insufficiency was associated with diabetes mellitus (relative risk, 2.1; 95% confidence interval [CI], 1.3 to 3.3) and elevated hemoglobin A(1c) levels. Compared with subjects with normoglycemia (hemoglobin A(1c) </= 5.7%), the relative risk for moderate chronic renal insufficiency for patients in the upper quartile of hemoglobin A(1c) (>9.0%) was 2.7 (95% CI, 1.4 to 5.1). The development of moderate chronic renal insufficiency was also independently predicted by elevated maximum serum cholesterol level. Compared with subjects with maximum cholesterol levels of 250 mg/dL or less, the relative risk for those with maximum cholesterol levels greater than 350 mg/dL was 2.4 (95% CI, 1.1 to 5.2). Similar relative risks were obtained when moderate chronic renal insufficiency was defined by the development of an increase in serum creatinine level. Hypercholesterolemia was also associated with moderate chronic renal insufficiency among persons without diabetes. In conclusion, the risk for developing moderate chronic renal insufficiency is increased by diabetes and elevated hemoglobin A(1c) and serum cholesterol levels. Modification of these risk factors may decrease the incidence of moderate chronic renal insufficiency.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10922305     DOI: 10.1053/ajkd.2000.8971

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  12 in total

1.  Inhibitor of differentiation 3, a transcription factor, regulates hyperlipidemia-associated kidney disease.

Authors:  Dominika Nackiewicz; Paromita Dey; Barbara Szczerba; Saleh Mohammad; Jennifer L Kaplan; Coleen A McNamara; Umesh S Deshmukh; Harini Bagavant
Journal:  Nephron Exp Nephrol       Date:  2014-05-16

Review 2.  Lipid nephrotoxicity: new concept for an old disease.

Authors:  Leonard Gyebi; Zohreh Soltani; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2012-04       Impact factor: 5.369

3.  Longitudinal lipid trends and adverse outcomes in patients with CKD: a 13-year observational cohort study.

Authors:  Ching-Wei Tsai; Han-Chun Huang; Hsiu-Yin Chiang; Chih-Wei Chung; Shih-Ni Chang; Pei-Lun Chu; Chin-Chi Kuo
Journal:  J Lipid Res       Date:  2019-01-14       Impact factor: 5.922

Review 4.  Dyslipidemia and progression of kidney disease: role of lipid-lowering drugs.

Authors:  Vito M Campese
Journal:  Clin Exp Nephrol       Date:  2014-02-18       Impact factor: 2.801

5.  Contribution of hyperglycemia on diabetic complications in obese type 2 diabetic SDT fatty rats: effects of SGLT inhibitor phlorizin.

Authors:  Yoshiaki Katsuda; Tomohiko Sasase; Hironobu Tadaki; Yasuko Mera; Yu Motohashi; Yusuke Kemmochi; Kaoru Toyoda; Kochi Kakimoto; Shinichi Kume; Takeshi Ohta
Journal:  Exp Anim       Date:  2015-01-22

Review 6.  Risk Factors for Development and Progression of Chronic Kidney Disease: A Systematic Review and Exploratory Meta-Analysis.

Authors:  Wan-Chuan Tsai; Hon-Yen Wu; Yu-Sen Peng; Mei-Ju Ko; Ming-Shiou Wu; Kuan-Yu Hung; Kwan-Dun Wu; Tzong-Shinn Chu; Kuo-Liong Chien
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

7.  Microalbuminuria measured by three different methods, blood pressure and cardiovascular risk factors in elderly Swedish males.

Authors:  Gösta Florvall; Samar Basu; Johanna Helmersson; Anders Larsson
Journal:  Anal Chem Insights       Date:  2008-09-02

8.  Waist circumference, not body mass index, is associated with renal function decline in korean population: hallym aging study.

Authors:  Hyunju Oh; Shan Ai Quan; Jin-Young Jeong; Soong-Nang Jang; Jung Eun Lee; Dong-Hyun Kim
Journal:  PLoS One       Date:  2013-03-25       Impact factor: 3.240

9.  Renal function can improve at any stage of chronic kidney disease.

Authors:  Lise Weis; Marie Metzger; Jean-Philippe Haymann; Eric Thervet; Martin Flamant; François Vrtovsnik; Cédric Gauci; Pascal Houillier; Marc Froissart; Emmanuel Letavernier; Bénédicte Stengel; Jean-Jacques Boffa
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

10.  Electronegative low density lipoprotein induces renal apoptosis and fibrosis: STRA6 signaling involved.

Authors:  Chao-Hung Chen; Liang-Yin Ke; Hua-Chen Chan; An-Sheng Lee; Kun-Der Lin; Chih-Sheng Chu; Mei-Yueh Lee; Pi-Jung Hsiao; Chin Hsu; Chu-Huang Chen; Shyi-Jang Shin
Journal:  J Lipid Res       Date:  2016-06-02       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.